In using tumor markers for early
diagnosis and at early stages of neoplasm cases
in the period March 2004 - September 2010,
18,830 samples were processed, of which 10
574 samples were confirmed with a diagnosis of
cancer of various types, primary and metastatic
forms. The markers used were: hepatic (AFP,
CEA, CA 19-9), pancreatic (CEA, CA19-9), of
prostatic (CEA, PSA, acid and alkaline
phosphatase), breast (CEA, AC15-3, CA27, 29),
genital (CEA, CA125), lung (CEA),
gastrointestinal (CEA). The investigations were
conducted using the apparata LISA 200, Miura
9.2 and ELISA on peripheral blood.
The high frequency of this serious
disease in the study group (40.5% subjects with
confirmed cancer) should be a warning to
reconsider our lifestyle, habits and nutrition. | 
